Ronald Harold Wilfred Cooper Albireo Pharma, Inc. (ALBO) insider trading activity

Ronald Harold Wilfred Cooper is President and CEO of ALBIREO PHARMA, INC.. Currently has a direct ownership of 0 shares of ALBO, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 33,094 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Ronald Harold Wilfred Cooper Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	33,094 Reduced 100.0%	0 Common Stock
Jan 23 2023	SELL Open market or private sale	$46,296 $43.8 p/Share	1,057 Reduced 1.81%	57,444 Common Stock
Jan 19 2023	BUY Grant, award, or other acquisition	-	195,000 Added 43.58%	252,444 Common Stock
Oct 24 2022	SELL Open market or private sale	$17,994 $19.58 p/Share	919 Reduced 1.63%	55,461 Common Stock
Jul 22 2022	SELL Open market or private sale	$22,918 $24.67 p/Share	929 Reduced 1.62%	56,380 Common Stock
Apr 22 2022	SELL Open market or private sale	$30,031 $33.11 p/Share	907 Reduced 1.59%	56,082 Common Stock
Jan 24 2022	SELL Open market or private sale	$91,658 $24.88 p/Share	3,684 Reduced 6.07%	56,989 Common Stock
Sep 17 2021	SELL Payment of exercise price or tax liability	$229,774 $29.61 p/Share	7,760 Reduced 11.34%	60,673 Common Stock
Sep 17 2021	BUY Exercise of conversion of derivative security	$229,762 $19.19 p/Share	11,973 Added 14.89%	68,433 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	48,700 Added 46.31%	56,460 Common Stock

Also insider at

GBIO

Generation Bio Co. Healthcare

CCCC

C4 Therapeutics, Inc. Healthcare

Director

ENGN

enGene Holdings Inc.

Chief Executive Officer

RHW